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Recently, we have developed novel polyethylene glycol modiﬁed liposomes (bubble liposomes; BL) entrapping an ultrasound
(US) imaging gas, which can work as a gene delivery tool with US exposure. In this study, we investigated the usefulness of US-
mediated gene transfer systems with BL into synoviocytes in vitro and joint synovium in vivo. Highly eﬃcient gene transfer could
be achievedin thecultured primary synoviocytes transfected withthecombinationofBLandUSexposure, comparedto treatment
with plasmid DNA (pDNA) alone, pDNA plus BL, or pDNA plus US. When BL was injected into the knee joints of mice, and US
exposure was applied transcutaneously to the injection site, highly eﬃcient gene expression could be observed in the knee joint
transfected with the combinationofBL andUS exposure, compared to treatment with pDNA alone,pDNA plus BL, or pDNA plus
US. The localized and prolonged gene expression was also shown by an in vivo luciferase imaging system. Thus, this local gene
delivery system into joint synovium using the combination of BL and US exposure may be an eﬀective means for gene therapy in
joint disorders.
1.Introduction
Intra-articular gene therapy is considered a feasible tech-
nique to deliver therapeutic proteins to suppress inﬂam-
mation and destruction of the joints in rheumatoid arthritis
and osteoarthritis, because it could minimize extra-articular
adverse eﬀects linked to the systemic injection of drugs
[1, 2]. To achieve successful gene therapy in a clinical setting,
itis criticalthat the genedelivery systemis safe, easy toapply,
and provides therapeutic transgene expression. Previous
studies using viral vectors reported the successful transfer
of therapeutic genes into the target cells in joint diseases
[1, 2], but because of the considerable immunogenicity
related to the use of viruses, nonviral gene transfer still
needs to be developed [3]. Recently, it has been reported
that therapeutic ultrasound as a physical non-viral gene
transfer method enables genes to permeate cell membranes.
Acoustic cavitation is involved in the mechanism of gene
transfer [4–8]; however, to achieve eﬃcient gene transfer,
high intensity ultrasound (US) is needed, leading to tissue
damage[9–11].Incontrast,low-intensity USincombination
with microbubbleshas recently acquired much attentionas a
safemethodofgenedelivery[12–16];however,microbubbles
have problems with size, stability, and targeting function.
Liposomes have been known as drug, antigen, and gene
delivery carriers [17–21]. To solve the above-mentioned
issues of microbubbles, we previously developed pol-
yethylene glycol- (PEG-) modiﬁed liposomes entrapping
echo contrast, bubble liposomes (BL), which can function
as a novel gene delivery tool by applying them with US
exposure [22–27].
The establishment of a method to deliver genes into
joints by the combination of BL and US exposure may
facilitate the developmentof a safe and eﬃcient gene therapy
for joint disorders. In the present study, we investigated the
usefulness of US-mediated gene transfer systems with BL
into synoviocytes in vitro and the joint synovium in vivo.2 Journal of Drug Delivery
2.Materialsand Methods
2.1. Preparation of Bubble Liposomes. Bubbleliposomes were
prepared by the previously described methods [22, 23, 26].
Brieﬂy, PEG liposomes composed of 1,2-dipalmitoyl-sn-
glycero-3-phosphocholine (DPPC) (NOF Corporation,
Tokyo, Japan) and 1,2-distearoyl-sn-glycero-3-phosphatidyl-
ethanolamine-polyethylen eglycol (DSPE-PEG2000-OMe)
(NOF Corporation) in a molar ratio of 94:6 were prepared
by a reverse phase evaporation method. In brief, the reagents
were dissolved 1:1 (v/v) in chloroform/diisopropyl ether.
Phosphate-buﬀered saline was added to the lipid solution,
and the mixture was sonicated and then evaporated at
47◦C. The organic solvent was completely removed, and
the size of the liposomes was adjusted to less than 200nm
using extruding equipment and a sizing ﬁlter (pore size:
200nm) (Nuclepore Track-Etch Membrane, Whatman
plc, UK). The lipid concentration was measured using a
Phospholipid C test Wako (Wako Pure Chemical Industries,
Ltd., Osaka, Japan). BL were prepared from liposomes
and perﬂuoropropane gas (Takachio Chemical Ind. Co.
Ltd., Tokyo, Japan). First, 2mL sterilized vials containing
0.8mL liposome suspension (lipid concentration: 1mg/mL)
were ﬁlled with perﬂuoropropane gas, capped, and then
pressurized with a further 3mL perﬂuoropropane gas.
The vial was placed in a bath-type sonicator (42kHz,
100W) (BRANSONIC 2510j-DTH; Branson Ultrasonics
Co., Danbury, Conn, USA) for 5min to form BL.
2.2. Plasmid DNA. The plasmid pCMV-Luc is an expression
vector encoding the ﬁreﬂy luciferase gene under the con-
trol of a cytomegalovirus promoter. The plasmid pDsRed-
Express-N1 (Clontech Laboratories, Inc., Mountain View,
Calif, USA) is an expression vector encoding the red
ﬂuorescent protein under the control of a cytomegalovirus
promoter.
2.3. Transfection of Plasmid DNA into Primary Synovio-
cytesUsing Bubble Liposomes. Primary synoviocytes (HFLS),
which are primary ﬁbroblast-like cells derived from the
inﬂamed synovial tissue of rheumatoid arthritis patients,
were purchased from Cell Applications, Inc. (San Diego,
Calif, USA). The culture was performed according to the
manufacturer’s instructions. The day before transfection,
cells (3 × 104) were seeded in the wells of a 48-well
plate (ASAHI TECHNOGLASS CO., Chiba, Japan). Five
micrograms of pDNA and 60μg BL were mixed together
with culture medium containing 10% FBS and added to the
cells. The cells were immediately exposed to US (frequency,
2M H z ,d u t y ,5 0 % ;b u r s tr a t e ,2 . 0H z ;i n t e n s i t y ,2 . 5W / c m 2)
for10sec through a 6-mm diameter probe placedin thewell.
A Sonopore 3000(NEPA GENE, Co., Ltd., Chiba, Japan) was
used to generate the US. The cells were washed twice with
culture medium and cultured for two days. The cell lysate
was prepared with lysis buﬀer (0.1M Tris-HCl (pH 7.8),
0.1%TritonX-100,and2mM EDTA).Luciferaseactivitywas
measuredusingaluciferaseassaysystem(Promega,Madison,
WI) and a luminometer (LB96V; Belthold Japan Co. Ltd.,
Tokyo, Japan). The activity is indicated as relative light units
(RLU) per mg of protein.
2.4. Transfection of Plasmid DNA with Lipofectamine 2000.
The day before transfection, HFLS-RA(4×104) were seeded
in the wells of a 48-well plate (ASAHI TECHNOGLASSCO.,
Chiba, Japan). Then, 0.25μg pDNA (ﬁnal concentration,
25nM) wsa diluted in Opti-MEM (GIBCO). Next, 1.25μg
Lipofectamine 2000(LF2000)(InvitrogenJapan K.K.,Tokyo,
Japan) was diluted in Opti-MEM. These solutions were
mixed and added to the cells. After 4 and 24 hours,
the cells were washed with PBS and cultured for two
days. The experiments were performed according to the
manufacturers’ instructions.
2.5. Measurement of Luciferase and DsRed Expression. Cell
lysate was prepared with lysis buﬀer (0.1M Tris-HCl (pH
7.8), 0.1% Triton X-100, and 2mM EDTA). Luciferase activ-
ity was measured using a luciferase assay system (Promega,
Madison, WI) and a luminometer (LB96V; Belthold Japan
Co. Ltd.). The activity is indicated as relative light units
(RLU) per mg protein. To analyze DsRed expression, the
treated cells were observed with a ﬂuorescence microscope
(Axiovert 200M; Carl Zeiss).
2.6.In VivoGeneDelivery intotheJointSynoviumofMicewith
Bubble Liposomes and Ultrasound Exposure. To determine
the eﬃciency of gene delivery, animals were divided into
ﬁve experimental groups and one control group (n = 4i n
each group). ICR mice (5 weeks old, male) were anesthetized
with an i.p. injection of sodium pentobarbital (80mg/kg)
throughout each procedure. A 40μL suspension of pDNA
(20μg) and BL (30μg) was injected into the knee joint of the
ICR mice, and US exposure (frequency, 1MHz; duty, 50%;
intensity, 2W/cm2; time, 60sec) was immediately applied
at the injection site. Five days after the injection, the mice
were euthanized and sacriﬁced, and the knee joint tissue in
the US-exposed area was collected and homogenized. The
tissue homogenates were prepared with lysis buﬀer (0.1M
Tris-HCl (pH 7.8), 0.1% Triton X-100, and 2mM EDTA).
Luciferase activity was measured using a luciferase assay
system (Promega,Madison, WI) andaluminometer(LB96V;
Belthold Japan Co. Ltd.).Activity is indicated as relative light
units (RLU) per mg of protein.
2.7. In Vivo Luciferase Imaging. To determine the eﬃciency
of gene delivery, animals were divided into ﬁve experimental
groups and one control group (n = 4 in each group). ICR
mice (5 weeks old, male) were anesthetized with an i.p.
injection of sodium pentobarbital (80mg/kg) throughout
each procedure. A 40μL suspension of pDNA (20μg) and
BL (30μg) was injected into the knee joint of the ICR mice,
and US exposure (frequency, 1MHz; duty, 50%; intensity,
2W/cm 2; time, 60sec) was immediately applied at the
injection site. Several days after the injection, the mice were
anaesthetized and i.p. injected with D-luciferin (150mg/kg)
(Xenogen Corporation, Calif, USA). After 10min, luciferase
expression was observed with an in vivo luciferase imagingJournal of Drug Delivery 3
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Figure 1: Luciferase expression in HFLS transfected with bubble liposomes and ultrasound exposure compared with Lipofectamine 2000.
pDNA (pCMV-Luc) and BL were mixed together with culture medium and added to the HFLS. The cells were immediately exposed to US
(frequency, 2MHz; duty, 50%; intensity, 2.5W/cm2; US exposure time, 10sec.). The cells were washed and cultured for 2 days, and then
luciferase activity was determined as described in Section 2 . The transfection of pDNA by LF2000 was also performed according to the
manufacturers’ instructions. All data are shown as the mean ± SD (n = 4). ∗∗P<. 05 versus other treatment groups. BL: bubble liposomes;
US: ultrasound exposure.
Cont.
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DNA + US
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DNA + BL + US
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Figure2:DsRedexpressioninHFLStransfectedwithbubbleliposomesandultrasoundexposure comparedwithLipofectamine2000.pDNA
(pDsRed-Express-N1) and BL were mixed together with culture medium and added to the HFLS. The cells were immediately exposed to
US (frequency, 2MHz; duty, 50%; intensity, 2.5W/cm2; US exposure time, 10sec.). The cells were washed and cultured for 2 days and then
treated cells wereexamined byaﬂuorescence microscopeoriginalmagniﬁcationX200.TransfectionofpDNA by LF2000wasalsoperformed.
BL: bubble liposomes;US: ultrasound exposure. Fluorescence, (a–d); phase contrast, (e–h).
system (IVIS) (Xenogen Corporation). The image of a
representative of the 4 mice was used for each treatment
group in this experiment.
2.8. Immunohistochemistry. The gene-transfected joint tis-
sues were preserved in 10% PFA, decalciﬁed with EDTA,
a n dt h e ne m b e d d e di np a r a ﬃn and sectioned. Sections
(3μm thickness) were evaluated for the expression of
luciferase protein by immunostaining. The sections were
deparaﬃnized inxylene, rehydrated through graded ethanol,
and equilibrated in PBS. The sections were incubated
with biotin-labeled rabbit antiluciferase antibody (Cortex
Biochem, San Leandro, Calif, USA). The following day, after
three washes in PBS, immunoreactivity was detected using
an antigoat IgG/HRP and diaminobenzidine (DAB). After
color development, the joint sections were counterstained
with hematoxylin and were then dehydrated, cleared, and
mounted on slides.4 Journal of Drug Delivery
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Figure 3: Eﬀect of ultrasound exposure time on transfection with
bubble liposomes into HFLS. pDNA (pCMV-Luc) and BL were
mixed together with culture medium and added to the HFLS. The
cells were immediately exposed to US (intensity, 2.5W/cm2;U S
exposure time, 5–60sec.). The cells were washed and cultured for 2
days,andthenluciferaseactivitywasdetermined.Alldataareshown
as the mean ± SD (n = 4). BL: bubble liposomes; US: ultrasound
exposure.
1E+05
1E+06
1E+07
L
u
c
i
f
e
r
a
s
e
a
c
t
i
v
i
t
y
(
R
L
U
/
m
g
p
r
o
t
e
i
n
)
< 1E +04
pDNA 0.10 .51 .52 .54
(W/cm2)
pDNA + BL + US
Figure 4: Eﬀect of ultrasound intensity on transfection with
Bubble liposomes into HFLS. pDNA (pCMV-Luc) and BL were
mixed together with culture medium and added to the HFLS. The
cells were immediately exposed to US (intensity, 0.1–4W/cm2;U S
exposure time, 10sec.). The cells were washed and cultured for 2
daysandthenluciferaseactivity wasdetermined. Alldata areshown
as the mean ± SD (n = 4). BL: bubble liposomes; US: ultrasound
exposure.
2.9. In Vivo Studies. Animal use and relevant experimental
procedures were approved by Tokyo University of Pharmacy
and Life Science Committee and Teikyo University on the
Care and Use of Laboratory Animals. All experimental
protocols for animal studies were in accordance with the
Principle of Laboratory Animal Care at Teikyo University.
2.10.StatisticalAnalyses. Alldataareshownasthemean±SD
(n = 4 or 6). Data were considered signiﬁcant when P<. 05.
The t-test was used to calculate statistical signiﬁcance.
3.Resultsand Discussion
3.1. Gene Transfection with Bubble Liposomes and Ultra-
sound Exposure into Synoviocytes In Vitro. It is known
that microbubbles improve cell and tissue permeability
by cavitation upon US exposure [11–15]. We ﬁrst tried
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Figure 5: In vivo luciferase expression in the joint synovium after
transfection with bubble liposome and ultrasound exposure. A
suspension of pDNA and BL was injected into the knee joint of
the mice, and US exposure (frequency, 1MHz; duty, 50%; intensity,
2W/cm 2;time,60sec)wasimmediatelyapplied attheinjection site.
Five daysafterinjection,thekneejointtissueintheUS-exposed area
wascollected andhomogenized.Luciferaseactivitywasdetermined.
Alldata areshownasthemean±SD(n = 4). ∗∗P<. 05versus other
treatment groups. BL: bubble liposomes; US: ultrasound exposure.
to transfect naked pDNA (pCMV-Luc) into primary syn-
oviocytes (HFLS), which are primary ﬁbroblast-like cells
derived from the inﬂamed synovial tissue of rheumatoid
arthritis patients, by BL and/or US (Figure 1). As a result,
luciferase activity in the group receiving a combination of
BL with US exposure was 400- or 30-fold higher than that
of the group treated with pDNA alone or pDNA plus US,
respectively (Figure 1). For basic research, LF2000 is often
used to transfect plasmid DNA or siRNA to analyze gene
function in various cultured cell lines. We, therefore, com-
pared with a commercially available transfection reagent,
LF2000; however, luciferase activity was very low (Figure 1).
Figure 2 shows the transfection eﬃciency using DsRed
expressing plasmid DNA. The numbers of DsRed-positive
cells markedly increased with the combination of BL and US
exposure compared to the group treated with pDNA plus
US or LF2000. It may be diﬃcult to achieve eﬃcient gene
transfection to primary cultured cells by LF2000, because
al o wl e v e lo ft r a n s f e c t i o ne ﬃciency in human umbilical
vein endothelial cells (HUVEC) was also observed (data
not shown). Our previous report showed that when the
intracellular localization of ﬂuorescent-labeled siRNA in
COS7 cells just after transfection with BL and US exposure
is examined by confocal laser scanning microscopy (CLSM)
analysis, signiﬁcant cytoplasmic distribution of siRNA can
be observed [25]. Consequently, we concluded that unlike
the transfection method with LF2000 involving endocytosis,
transfection with BL and US does not involve endocytosis,
but siRNA was directly and quickly introduced into the
cytoplasm by physical force. Similarly, when ﬂuorescent-
labeled plasmid DNA was delivered to COS7 cells by the
combination of BL and US exposure, plasmid DNA couldJournal of Drug Delivery 5
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Figure 6:In vivo luciferaseimaging.AsuspensionofpDNA andBLwasinjected intothe kneejointofthemice,andUSexposure (frequency,
1M H z ;d u t y ,5 0 % ;i n t e n s i t y ,2W / c m 2; time, 60sec) was immediately applied at the injection site. Luciferase expressions after transfection
into the joint treated with pDNA, or pDNA plus BL plus US exposure were observed with an in vivo luciferase imagingsystem for2–24 days.
be also distributed in the cytoplasm and nucleus (data
not shown). Therefore, these results suggested that the
combination of BL and US exposure facilitated the eﬃcient
transfection of pDNA into the cells due to the induction of
cavitation.
Previously, our report demonstrated that gene transfec-
tion eﬃciency in vitro could be aﬀected by increasing the
US exposure time and intensity [22, 23]. We, therefore,
examined the eﬀect of US exposure time and intensity
on transfection with BL into HFLS. High gene expression
could be achieved by only 5 seconds of US exposure. In
contrast, gene expression fell with a longer exposure time,
60sec. (Figure 3),which might have been due to cytotoxicity.
When we applied a range of US intensity (0.1–4W/cm2)i n
transfection, US intensity of 2.5W/cm2 was modestly higher
than other treated groups (Figure 4). These results suggest
that BL with US exposure is a useful gene delivery tool for in
vitro transfection in synoviocytes.
3.2. Gene Transfection with Bubble Liposomes and Ultrasound
Exposure into Joint Synovium In Vivo. A local gene delivery
system to the joint synovium by BL and US exposure may
be easily applied, because the injected BL may be retained
in the conﬁned joint space and percutaneous US exposure
may induce cavitations on the surface of the synovium.
We, therefore, attempted to deliver pCMV-Luc, luciferase-
expressing plasmid DNA, into the joint synovium of mice
using BL and US and to determine the level of the gene
expression. A 40μL solution of pDNA and BL was injected
i n t ot h ek n e ej o i n to ft h em i c e ,a n dU Se x p o s u r ew a s
immediately applied at the injection site. As a result, marked
gene expression could be enhanced eﬃciently only with the
combination of BL and US exposure when compared with
other treatments (Figure 5). Exceeding our expectations,
their gene expression was 500-fold higher than pDNA
injection alone. We also observed luciferase gene expression
area in the whole body using an in vivo luciferase imaging
systemduring2–24daysaftertransfectionintoajointtreated
with pDNA, BL, and US exposure. The high level of gene
expression persisted for7–24daysaftertransfection using BL
and US exposure (Figure 6). Gene expression was restricted
to the area of US exposure. In contrast, no signal in the
whole body was observed in the group with pDNA injection
alone. This suggested that the combination of BL and US
exposure facilitated the eﬃcient transfection of pDNA into
the joint tissue due to the induction of cavitation. We
next investigated the localization of the transfected gene
expression in the transfected joint by immunohistochemical
analysis. This showed that the luciferase protein expression
was limited to the synovial ﬁbroblasts in the joint space. No6 Journal of Drug Delivery
(a) (b)
Figure 7: Immunostaining for luciferase in synovial ﬁbroblast. Local gene expression in joint synovium after intra-articular gene delivery
using BL and US. Seven days after treatment, the expression of luciferase protein was mostly limited to the synovial ﬁbroblasts. (a) H&E
staining in joint sections. (b) Immunohistochemicallocalizationof luciferase (arrows).Scale bar = 100μm.
expression was observed in other tissues such as articular
cartilage (Figure 7).
Gene transfer into cartilage may be diﬃcultbecausecavi-
tation induction with BL and US cannot reach chondrocytes
embedded in extracellular matrix in articular cartilage, lead-
ing to no transfection. However, successful gene transfection
intochondrocytesmightbeachievedbyBLandUSexposure,
because articular chondrocytes in RA or OA are exposed by
degradation of the extracellular matrix in articular cartilage
in this stage of the disease.
It is known that cartilage degradation is the main
pathological feature in OA; however, synovial factors are
closely related to this progress [28], while synovitis is the
main pathological feature of RA. Therefore, intra-articular
gene therapy by BL and US exposure could be considered a
feasible technique to deliver therapeutic proteins to suppress
inﬂammation and destruction of the joints in RA and OA,
because it could minimize extra-articular adverse eﬀects
linked to systemic injection of drugs; however, further study
will be required for their assessment.
4.Conclusions
In this study, we showed that the combination of BL and
US exposure could be an eﬀective gene delivery method
into synoviocytes in vitro and the joint synovium in vivo.I n
the future, this local gene delivery method with BL and US
exposure might be used in non-viral gene therapy for joint
disorders, such as RA and OA.
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